Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

Fixed-Dose Combo Tx Duzallo Approved for Uncontrolled Gout

By Aug 21, 2017

This fixed-dose combination product combines lesinurad, a uric acid transporter 1 (URAT1) inhibitor, with allopurinol, a xanthine oxidase inhibitor in one tablet.

FDA Panel to Evaluate Safety of Prescription Cough Medicines for Kids

By Aug 21, 2017

Specifically, this panel of independent experts will discuss the the benefits and risk associated with the use of these products in this patient population as well as current treatment practices.

Type 2 Diabetes Injectable Therapy Will Soon Be Unavailable

By Aug 18, 2017

Tanzeum, a glucagon-like peptide-1 (GLP-1) receptor agonst, is indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes.

Targeting Premenstrual Breakthrough of Depression with OCs: Is it Effective?

By Aug 18, 2017

Premenstrual exacerbation (PME) of depression has been found to occur in roughly two-thirds of women with depressive disorders.

FDA Approves New Indication, Formulation for Lynparza

By Aug 18, 2017

The approvals were based on two, placebo-controlled trials (SOLO-2, Study 19) in patients with recurrent ovarian cancers who were in response to platinum-based therapy.

More Articles by Diana Ernst, RPh